JStar Capital Investments III, LLC
Open, writing first checksEmerging manager
Open: first sale Jan 2025, per Form D (fund age approximates vintage)
- Vintage
- 2025
- Fund size
- $2.82M to $5.5M (Form D)
- Stages
- Not stated
- Sectors
- Medical devices, Healthtech, Biotech
- Regions
- Global
01 · Thesis
JSTAR Capital Investments backs breakthrough med-tech solutions and treatments across cardiovascular, orthopedic and biopharma innovation. It targets unmet clinical needs, backs experienced leadership ahead of key inflection points, and prioritizes capital-efficient businesses with clear milestones.Inferred from the firm's website
02 · Initial check
$28K to $92K (estimated from fund size)
Estimated from Form D: $2.82M sold of a $5.5M target
03 · Who to approach
Named on this fund's Form D
- Jared Leger, Manager of Manager of Issuer
- Evan Pritchard, Manager of Manager of Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideFocused on breakthrough med-tech solutions and treatments across cardiovascular, orthopedic and biopharma innovation.
Our focus is on breakthrough med-tech solutions and treatments with the power to redefine what’s possible in medicine.
https://jstarinvestments.com/
06 · Sources
Last verified: Oct 28, 2026